Monika Tornsen
Director/Board Member at IMMUNIC, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hilde Furberg | F | 65 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 14 years |
| Daniel Vitt | M | 55 | 7 years | |
| William Chou | M | 51 | 2 years | |
| Barclay Phillips | M | 61 | 5 years | |
| Tamar Howson | F | 75 | 5 years | |
| Henrik Stenqvist | M | 57 | 2 years | |
| Johan Erik Häggblad | M | 65 | 17 years | |
| Jörg Neermann | M | 57 | 5 years | |
| Elmar Schnee | M | 65 | 5 years | |
| Kathleen Borthwick | F | 48 | 3 years | |
| Glenn Whaley | M | 56 | 5 years | |
| Jessica Breu | F | - | - | |
| Diane Parks | F | 71 | 5 years | |
| Margareta Elisabeth Björk | M | 63 | 2 years | |
| Richard Philipson | M | 60 | 4 years | |
| Fred Driscoll | M | 74 | 1 years | |
| Inderpal Singh | M | 58 | 3 years | |
| Mark Forman | M | 60 | 3 years | |
| Patrick Walsh | M | 41 | 3 years | |
| Åsa Hillsten | F | - | 1 years | |
| Marie Galay | F | - | 4 years | |
| Christopher Ngai | M | - | 4 years | |
| Fredrik Johansson | M | 47 | 7 years | |
| Hella Kohlhof | M | 51 | 7 years | |
| Frank Bringstrup | M | 65 | 5 years | |
| Sandra Frithiof | F | 49 | 2 years | |
| Richard Rudick | M | 73 | 1 years | |
| Krassimir Mitchev | M | - | 4 years | |
| Brian Gorman | M | 48 | - | |
| Duane Nash | M | 53 | 5 years | |
| Andreas Muehler | M | 60 | 8 years | |
| Renée Aguiar-Lucander | F | 62 | 7 years | |
| Lars Stubberud | M | 60 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Meeker | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 23 years |
| Bruce Goldsmith | M | 58 | 2 years | |
| Jan van den Bossche | M | 45 | 3 years | |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
| Carlo Incerti | M | 65 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
| Liam Ratcliffe | M | 60 | 3 years | |
| Mary Gray | M | 71 | 3 years | |
| Michael Halpin | M | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Vincent Ossipow | M | 55 | 7 years | |
| Michael Bonney | M | 65 | 3 years | |
| Tadataka Yamada | M | 77 | 4 years | |
| John Martin | M | 72 | 1 years | |
| TY Howton | M | 52 | 8 years | |
| Michael Kamarck | M | 73 | 1 years | |
| Yann Mazabraud | M | 51 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 1 years |
| E. Sutherland | M | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| David Weinstein | M | - | - | |
| Javier Cote-Sierra | M | 61 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 2 years |
| Nia Tatsis | M | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Adam Hansard | M | 48 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| Matthew Gall | M | 47 | 6 years | |
| Karen Anderson | M | - | - | |
| Simona King | F | 52 | 2 years | |
| Yun Xiang Zhu | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 17 years |
| Vaithianathan Palaniappan | M | - | 2 years | |
| Christina Rossi | F | 48 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| David Ford | M | 56 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 1 years |
| William Ciambrone | M | 60 | 3 years | |
| Desiree Luthman | M | 65 | 3 years | |
| Jill Quigley | F | 49 | 3 years | |
| Richard Peters | M | 61 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 9 years |
| Alexander Cumbo | M | 53 | 7 years | |
| Jean-Paul Kress | M | 59 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 2 years |
| Yamo Deniz | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
| Robin DeRogatis | F | - | - | |
| Andrew Udell | M | 54 | 5 years | |
| Gwendolyn Fisher | F | - | 2 years | |
| Sandy Mahatme | M | 59 | 8 years | |
| Kathryn Corzo | F | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 9 years |
| Eliseo Salinas | M | 69 | 1 years | |
| Jan Van den Bossche | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 56 | 75.68% |
| Sweden | 19 | 25.68% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Monika Tornsen
- Personal Network
